Plain-English translation of NCT05983809 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a robotic platform called Hunova to help people with multiple sclerosis improve their balance and walking ability. The robot provides guided exercises to strengthen your balance control, coordination, and trunk stability over 4 weeks of sessions. Researchers want to see if this technology can help reduce falls and improve daily movement and thinking skills.
Many people with multiple sclerosis struggle with balance and walking, which can lead to falls and affect their quality of life. This trial exists to see if robot-assisted exercises can be a helpful addition to standard care and might work better than standard rehabilitation alone.
You likely qualify if…
You likely don't qualify if…
You will visit the research center 3 times per week for 4 weeks, with each session lasting about 45 minutes on the Hunova robotic platform. The robot will guide you through exercises to improve your balance—both sitting and standing—and will include activities that challenge your coordination and trunk control. Then you'll have 4 weeks off from treatment while researchers observe how you're doing. The study lasts about 8 weeks total.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy